Resources for Food and Drug Administration (FDA)

FDA approves Vidacare's new biopsy system for the market

www.bizjournals.com

Vidacare Corp. has received Food and Drug Administration approval for the company's novel bone-marrow biopsy system for hematology/oncology.

The new technology is designed to increase control, improve core capture rates and reduce patient discomfort during bone-marrow biopsy procedures. San Antonio-based Vidacare will market the lithium-battery powered device under the OnControl Bone Marrow Biopsy System brand.

"The FDA's approval of the OnControl Biopsy System is a key milestone for Vidacare as well as patients requiring bone marrow biopsies," Vidacare President and CEO Philip Faris Jr. says.

View the Resource

Share or bookmarklet this web page at: